INSTRUCTIONAL COURSE EVALUATION

IC 25: Toxin- Safe Territory for Both Patients and Providers
Ed Wright, MD; Deborah Gaebler-Spira, MD; Colin Hovinga, Pharm D; Clifton Bergfeld, JD; Ana-Marie Rojas, MD

Learning Objective:
1) To understand issues around patient and practice safety related to neurolytics use.
2) To understand the roles of federal regulatory agencies relative to the pharmaceutical industry and the practice of healthcare.
3) To understand the treatment options and outcomes of systemic botulism.
4) To understand the current variable use and practice of neurolytic injections.

Question Title

* 1. Please indicate your opinion about each of the following statements.

  Strongly Agree Agree Neutral Disagree Strongly Disagree
The course followed description in the program.
The course began on time and was well paced.
The faculty communicated clearly and effectively.
The course used practical examples to teach points.
The faculty involved participants in the course.
The faculty allowed enough time for questions.
The course met its objectives as stated in the program.
The information presented will help me accomplish my professional responsibilities.
The course has given me a basis for making changes in my practice.

Question Title

* 2. Did this course have a commercial bias?

Question Title

* 3. Should the Academy repeat this course next year?

Question Title

* 4. Please suggest any topics of interest for a future course.

Question Title

* 5. General comments:

Thank you for taking the time to complete this evaluation. 
Your feedback is valued and greatly appreciated.
( Privacy & Cookie Notice

T